Who invested in Transcripta Bio

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$34Mraised across 2 rounds since 2024, from 2 sources

$10MVenture$24MSeries A

Latest round: Series A, $24MJul 2026
Step-upi: 2.4×
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026

$10MVenture$24MSeries A

First round: Venture, $10M
Biggest round: $24M
Between rounds: 2.3 years

The rounds

Jul 2026
Series A$24M2 new1 returning
Source recorded
Apr 2024
Venture$10M1 new
- BlueYard Capital
Source recorded

Founders and team

From Transcripta Bio's own website: 9 on the team.

Clayton MellinaCTO
Deanna WongVP of People & Operations
Ciaran O'LearyBoard Member
Daniel LarsonBusiness Development Manager
John LeeBoard Member
Katherine DyerPrincipal Research Associate
Michael BlancoAssociate Scientist
Onno FaberBoard Member
Zack LynchBoard Member

AdvisersBen ElowitzCarrie Rich

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2024Series A2026

BlueYard Capital

Gaingels

Mayo Clinic

Everyone who backed them

BlueYard CapitalVC firm2rounds

GaingelsPrivate equity1round

Mayo ClinicInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Transcripta Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.